In an industry where innovation directly impacts patient outcomes, market success requires deep clinical and commercial insight. GIC delivers the critical market intelligence that MedTech leaders, R&D teams, and investors need to navigate regulatory pathways, drive commercial success, and transform healthcare.
Cardiovascular, Orthopedics, Diagnostics, Surgical Robotics, Digital Health, IVD, Dental, Vision Care
Market Sizing, Competitive Benchmarking, Regulatory Strategy, M&A Due Diligence, Pricing & Reimbursement Analysis
Former MedTech Executives, Clinical Experts, Regulatory Specialists, Reimbursement Analysts, M&A Advisors
Annual Deep-Dive Reports, Quarterly Market Updates, Real-Time Regulatory & M&A Alerts
MedTech leaders partner with GIC to achieve mission-critical objectives:
The MedTech industry faces significant commercial and clinical challenges:
We analyze regulatory pathways, clinical trial designs, and approval timelines to help clients navigate the complex regulatory landscape and accelerate time-to-market.
Our reimbursement experts evaluate coverage policies, coding strategies, and payer dynamics to optimize market access and pricing strategies.
We provide detailed competitive analysis, market sizing, and trend analysis across all major MedTech sub-sectors.
Each report provides comprehensive coverage of the medical technology landscape.
Coronary stents, structural heart, pacing, and heart failure devices.
Joint reconstruction, spinal implants, and sports medicine.
MRI, CT, ultrasound, and point-of-care imaging systems.
Robot-assisted surgery systems and navigation platforms.
Molecular diagnostics, immunoassays, and point-of-care testing.
Patient monitoring, life support, and surgical equipment.
Software as a Medical Device, AI diagnostics, and remote monitoring.
Dental implants, orthodontics, intraocular lenses, and contact lenses.
FDA/EMA pathways, coverage decisions, and pricing strategies.
Growth opportunities in Asia, Latin America, and emerging economies.
Full access to market data, procedure volumes, and competitive benchmarks.
Clear guidance for MedTech executives and investors.
"The surgical robotics market is at an inflection point. Our analysis shows that hospitals adopting robotic surgery see 25% shorter length of stay and 30% lower readmission rates, driving accelerated adoption across specialties."
Lead Analyst, Surgical Robotics, GIC
The global in vitro diagnostics market is projected to reach $130 billion by 2028, driven by demand for point-of-care and molecular diagnostics.
GIC IVD Market Forecast, Q2 2025
Digital health apps and SaMD products received 45% more FDA clearances in 2024 compared to 2023, signaling rapid regulatory evolution.
GIC Digital Health Regulatory Tracker, Q1 2025
78% of health system executives say clinical evidence is now the #1 factor in device purchasing decisions.
GIC MedTech Purchasing Survey, Q4 2024
Connect with a GIC analyst to discuss our syndicated MedTech reports or to commission bespoke research on your specific commercial and clinical challenges.
Speak with a MedTech Analyst